Johnson & Johnson Reports Q4 and Full-Year 2023 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
Johnson & Johnson (JNJ) tops revenue estimates, reiterates forecast
January 23, 2024 6:27 AM ESTJohnson & Johnson's (NYSE: JNJ) reported today fourth-quarter results that exceeded analyst expectations.
Adjusted earnings per share (EPS) came in at $2.29, slightly surpassing the average analyst estimate of $2.28. The company also reported sales of $21.40 billion for the quarter, beating the estimated $21.00 billion.
Looking ahead,... More
Johnson & Johnson (JNJ) Tops Q4 EPS by 1c, Beats on Revenue; Reaffirms FY24 Growth Targets
January 23, 2024 6:20 AM EST(Updated - January 23, 2024 6:22 AM EST)
Johnson & Johnson (NYSE: JNJ) reported Q4 EPS of $2.29, $0.01 better than the analyst estimate of $2.28. Revenue for the quarter came in at $21.4 billion versus the consensus estimate of $21 billion.
The company re-confirms guidance for 2024 with operational sales growth of... More
